OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	133
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	127
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	87
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	85
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	80
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	77
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	71
New Developments in VHL-Associated Neuroendocrine Neoplasms	68
Management of Upper Tract Urothelial Carcinoma	65
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	51
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	51
Treatment of Metastatic Melanoma in the Elderly	49
Fatty Acid Metabolism and Cancer Immunotherapy	48
Prostate Cancer Immunotherapy—Finally in From the Cold?	41
Brain Prehabilitation for Oncologic Surgery	41
Surgical Management of Melanoma: Advances and Updates	40
Immunotherapy in Biliary Tract Cancers: Where Are We?	35
New Insights on Tramadol and Immunomodulation	34
Current Trends and Challenges of Microbiome Research in Prostate Cancer	34
NRG1 Fusions: The New Kid on the Block	34
Management of In-Transit Metastases	34
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	33
AXL Inhibitors: Status of Clinical Development	32
An Overview of Angiogenesis in Bladder Cancer	32
Engineered T Cells: CAR T Cell Therapy and Beyond	32

Head and Neck Mucosal Melanoma: Where Are We Now?	31
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	31
Cellular Therapy in NSCLC: Between Myth and Reality	30
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	29
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	29